Immune rosette inhibiting activity of serum from patients with chronic lupus erythematosus treated with chloroquin
Nagy, E.; Szegedi, G.; Tamási, P.; Sonkoly, I.
Dermatologische Monatschrift 164(6): 408-410
1978
ISSN/ISBN: 0011-9083 PMID: 308469 Document Number: 124265
Document emailed within 1 workday
Related Documents
Moyito, T.; Aotsuka, S.; Yokohari, R.; Moroi, Y.; Yokohari, R. 1976: Clinical application of Fc-rosette. 1. Inhibition of Fc-rosette formation by systemic lupus erythematosus sera. a method for detection of circulating immune complexes Ryumachi 16(1): 4-11Skibiński, G.; Zwoliński, J.; Wieczorek, Z. 1979: Modulation of e rosette forming activity of human lymphocytes by rosette inhibiting factor (RIF) ann rosette restoring factor (RRF) Archivum Immunologiae et Therapiae Experimentalis 27(4): 475-480
Cossermelli, W.; Lazzari, A.A.; Leser, P.G.; Fonseca, R. 1979: Rheumatoid rosette test in patients with degenerative osteoarticular disease, gouty arthritis and systemic lupus erythematosus Revista do Hospital das Clinicas 34(4): 181-184
Cárdenas-Mondragón, G.; Ulloa-Aguirre, A.; Isordia-Salas, I.; Goffin, V.; Leaños-Miranda, A. 2007: Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays Journal of Rheumatology 34(7): 1514-1521
Sumethkul, K.; Srivitidkul, S. 2017: Prevalence of Chronic Hepatitis B Infection in Patients with Systemic Lupus Erythematosus: Viral Reactivation and Impact on Disease Activity Journal of the Medical Association of Thailand 100(Suppl 1): S124-S130
Cairns, S.A.; London, A.; Mallick, N.P. 1980: The value of three immune complex assays in the management of systemic lupus erythematosus: an assessment of immune complex levels, size and immunochemical properties in relation to disease activity and manifestations Clinical and Experimental Immunology 40(2): 273-282
Merola, J.F.; Chang, C.A.; Sanchez, M.R.; Prystowsky, S.D. 2011: Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus? Journal of Drugs in Dermatology: Jdd 10(12): 1413-1420
Morimoto, C.; Sano, H.; Abe, T.; Homma, M.; Steinberg, A.D. 1982: Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes Journal of Immunology 129(5): 1960-1965
Rivero, I.; Morán de Vignoni, Z.; Bottari, C.; Diumenjo, M.; Coll, M.A. 1975: Lymphatic drainage in a case or systemic lupus erythematosus and lymphocytic rosette findings in the lymph Revista Clinica Espanola 138(4): 375-379
Okubo, Y. 1991: Analysis of components of immune complexes in sera of patients with systemic lupus erythematosus Ryumachi 31(1): 36-44
Greco, C.M.; Rudy, T.E.; Manzi, S. 2004: Effects of disease activity, pain, and distress on activity limitations in patients with systemic lupus erythematosus Journal of Rheumatology 31(2): 260-267
Wollina, U.; Knopf, B. 1986: Characterization of subepidermal immune deposits in clinically unchanged skin in patients with lupus erythematosus (SLE) Zeitschrift für Hautkrankheiten 61(14): 1023-1026
Zeng, F-qin.; Yin, R-fei.; Tan, G-zhen.; Guo, Q.; Xu, D-qing. 2004: Characterization of DNA antigens from immune complexes deposited in the skin of patients with systemic lupus erythematosus Chinese Medical Journal 117(7): 1066-1071
van Vollenhoven, R.F.; Morabito, L.M.; Engleman, E.G.; McGuire, J.L. 1998: Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months Journal of Rheumatology 25(2): 285-289
Lipnick, R.N.; Karsh, J.; Stahl, N.I.; Blackwelder, W.C.; Schiffman, G.; Klippel, J.H. 1985: Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives Journal of Rheumatology 12(6): 1118-1121
Rodríguez-Valverde, V.; Peña Sagredo, J.L.; Orte Martínez, J.; Novo Fernández, M.J.; Sánchez Andrada, S.; Sampedro Alvarez, J. 1982: Circulating immune complexes and C3 in patients with systemic lupus erythematosus. the relationship between clinical manifestations and nephropathy Medicina Clinica 78(9): 353-357
Ternovoĭ, K.S.; Gandzha, I.M.; Babynina, L.I.; Volobueva, Z.V.; Sukharenko, N.V.; Dibrova, T.N.; Selezneva, T.N.; Ermekova, V.M. 1990: The levels of circulating immune complexes and immunoglobulins in patients with systemic lupus erythematosus and rheumatoid arthritis Vrachebnoe Delo 4: 48-50
Robak, E.; Sysa-Jedrzejewska, A.; Dziankowska, B.; Torzecka, D.; Chojnowski, K.; Robak, T. 1998: Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity Archivum Immunologiae et Therapiae Experimentalis 46(6): 375-380
Sullivan, K.E.; Wisnieski, J.J.; Winkelstein, J.A.; Louie, J.; Sachs, E.; Choi, R.; Veksler, E.; Goldman, D.; Petri, M. 1996: Serum complement determinations in patients with quiescent systemic lupus erythematosus Journal of Rheumatology 23(12): 2063-2067
Nesterenko, G.B.; Kogon, G.K.; Bashmakov, G.V.; Ploskaia, L.M.; Didenko, I.G. 1981: Nonspecific defense mechanisms and immune responsiveness in patients with eczema, systemic lupus erythematosus, psoriasis and dermatitis medicamentosa Vestnik Dermatologii i Venerologii 3: 21-24